Speaker advocates chemo-based salvage in HLNovember 5, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Brentuximab tops chemo in HL, doc saysNovember 5, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Risk factors for premature menopause in HL survivorsAugust 25, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Screening catches breast cancer early in HL survivorsJune 5, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Inhibitor gets breakthrough designation for HLMay 21, 2014Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
Omitting RT can increase risk of relapse in HLMarch 21, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Mutations appear to drive lymphoma developmentMarch 13, 2014Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Brentuximab vedotin approved in JapanJanuary 22, 2014Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
Panobinostat shows promise in refractory Hodgkin lymphomaDecember 9, 2009Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
